Patent · US Active

Antibodies which bind to the human CC chemokine receptor 4 and uses thereof

US8895007B2 · kind B2 · utility

1Cited by

1References

13Claims

0Family size

Assignee

Affitech Research AS · NO

Inventors

Urs Beat Hagemann · Oslo, NO
Remko Albert Griep · Slemmestad, NO
Herald Reiersen · Sofiemyr, NO
Sergej KIPRIJANOV · Oslo, NO

Key dates

Filing date	Dec 7, 2011
Grant date	Nov 25, 2014
Priority date	—
Expiry date	May 6, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/7158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antibodies which bind to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4) and which are capable of inhibiting the binding of macrophage-derived chemokine (MDC) and/or thymus and activation regulated chemokine (TARC) to CCR4. Also provided are inter alia immunoconjugates and compositions comprising such antibodies and methods and uses involving such antibodies, particularly in the medical and diagnostic fields.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.